Patterson Companies, a leading distributor in the dental and animal health sectors, entered a definitive agreement to be acquired by Patient Square Capital, a healthcare-focused private equity firm. 

Patterson shareholders will receive $31.35 per share in cash—representing a ~49 percent premium to its 30-day VWAP—with the deal valuing the transaction at approximately CAD5.5billion (approx. USD4.1billion). The acquisition is financed via a combination of committed equity and debt and includes a 40-day “go-shop” period.